What is Tesamorelin?
5 min read · Updated July 2026 · MY PEPTIDES Research Team
Key facts
Tesamorelin is a synthetic analogue of human growth-hormone-releasing hormone (GHRH 1-44), engineered with structural modifications that increase its stability compared with the native peptide. That stability makes it a dependable tool for studying hypothalamic–pituitary communication and growth-hormone regulatory pathways under controlled laboratory conditions. In biochemical and cellular systems it binds to and activates the GHRH receptor on pituitary-derived cells, initiating intracellular cascades that regulate growth-hormone synthesis and secretion. Experimental work commonly characterises its receptor-binding behaviour, cAMP-dependent signalling and downstream transcriptional responses under defined exposure conditions. As observed effects vary with concentration, exposure duration and model system, it is used to characterise GHRH-receptor signalling rather than to infer physiological outcomes. MY PEPTIDES supplies Tesamorelin in a sealed vial with a batch-specific Certificate of Analysis (HPLC and mass spectrometry), stored refrigerated at 2–8°C. It is supplied strictly for in-vitro laboratory research use only — not for human or veterinary use, and carries no therapeutic claims.
Tesamorelin is a synthetic analogue of human growth-hormone-releasing hormone (GHRH 1-44), engineered with structural modifications that increase its stability compared with the native peptide. That stability is what makes it a dependable tool for studying hypothalamic–pituitary communication and growth-hormone regulatory pathways under controlled laboratory conditions.
Research use only. Tesamorelin is supplied strictly for in-vitro laboratory research. This page does not describe dosing, administration, or use in humans or animals, and makes no therapeutic claims.
What researchers study
In biochemical and cellular systems, Tesamorelin binds to and activates the GHRH receptor on pituitary-derived cells, initiating intracellular cascades that regulate growth-hormone synthesis and secretion. Experimental work commonly characterises receptor-binding behaviour, cAMP-dependent signalling, and downstream transcriptional responses under defined exposure conditions. As always, observed effects vary with concentration, exposure duration and model system, so it is used to characterise GHRH-receptor signalling rather than to infer physiological outcomes.
Typical research applications include:
- Analysing GHRH-receptor activation and associated signalling pathways
- Studying growth-hormone regulatory mechanisms in pituitary-based models
- In-vitro work on peptide stability, receptor selectivity and signalling specificity
How it is supplied
Tesamorelin is supplied in a sealed vial with a batch-specific Certificate of Analysis (HPLC + mass spectrometry), stored refrigerated at 2–8°C.
Related reading
- Compare with another GHRH analogue: what is CJC-1295?
- New to the topic? What are research peptides?
Tesamorelin Peptide
Available now from MY PEPTIDES — 99%+ purity, COA with every order, fast UK dispatch.
Frequently asked questions
- What is Tesamorelin?
- A stabilised synthetic GHRH (1-44) analogue used in laboratory research to study growth-hormone-axis receptor signalling. Supplied for in-vitro research use only.